FDA Warning Letter — Shandong Analysis And Test Center

Case 524254 — FEI 3011060456

The FDA took a Warning Letter action against Shandong Analysis And Test Center on Jun 22, 2017 (Jinan, China). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
Shandong Analysis And Test Center
Date
Jun 22, 2017
Fiscal Year
2017
Product Type
Drugs
Center
CDER
Location
Jinan (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.